A Phase I/II Trial of Nexavar, Avastin and Eloxatin in Patients With Metastatic Malignant Melanoma
Phase of Trial: Phase I/II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Bevacizumab (Primary) ; Oxaliplatin (Primary) ; Sorafenib (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Therapeutic Use
- 27 Feb 2017 Last checked against ClinicalTrials.gov record.
- 09 Oct 2007 New trial record.